Bremelanotide (PT-141) for Female Sexual Dysfunction: Comprehensive Preclinical CNS Mechanism Review
This review covers bremelanotide's mechanism for female sexual function: central melanocortin MC3R/MC4R activation in hypothalamic and limbic sexual arousal circuits, with evidence for enhancing desire, arousal, and satisfaction.
Quick Facts
What This Study Found
Bremelanotide activates female sexual function through MC3R/MC4R in hypothalamic/limbic sexual circuits, enhancing desire and arousal through dopaminergic and oxytocinergic pathway modulation — the comprehensive CNS mechanism supporting its clinical development for female HSDD.
Key Numbers
How They Did This
review study on pt-141, melanotan.
Why This Research Matters
Relevant for pt-141, melanotan, sexual-health.
The Bigger Picture
Advances peptide research.
What This Study Doesn't Tell Us
See abstract.
Questions This Raises
- ?Further research needed.
- ?Clinical translation to evaluate.
Trust & Context
- Key Stat:
- Key finding Bremelanotide activates female sexual function through MC3R/MC4R in hypothalamic/limbic sexual circuits, enhancing desire and arousal through dopamine
- Evidence Grade:
- moderate evidence.
- Study Age:
- Published in 2007.
- Original Title:
- Bremelanotide: an overview of preclinical CNS effects on female sexual function.
- Published In:
- The journal of sexual medicine, 4 Suppl 4, 269-79 (2007)
- Authors:
- Pfaus, James, Giuliano, François, Gelez, Hélène
- Database ID:
- RPEP-01279
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What was studied?
Bremelanotide (PT-141) for Female Sexual Dysfunction: Comprehensive Preclinical CNS Mechanism Review
What was found?
This review covers bremelanotide's mechanism for female sexual function: central melanocortin MC3R/MC4R activation in hypothalamic and limbic sexual arousal circuits, with evidence for enhancing desire, arousal, and satisfaction.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-01279APA
Pfaus, James; Giuliano, François; Gelez, Hélène. (2007). Bremelanotide: an overview of preclinical CNS effects on female sexual function.. The journal of sexual medicine, 4 Suppl 4, 269-79.
MLA
Pfaus, James, et al. "Bremelanotide: an overview of preclinical CNS effects on female sexual function.." The journal of sexual medicine, 2007.
RethinkPeptides
RethinkPeptides Research Database. "Bremelanotide: an overview of preclinical CNS effects on fem..." RPEP-01279. Retrieved from https://rethinkpeptides.com/research/pfaus-2007-bremelanotide-an-overview-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.